FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.7  |  FHIR Version n/a  User: [n/a]

8940801000001103: Re-introduced (qualifier value)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
40298601000001113 Re-introduced (qualifier value) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
40298701000001115 Re-introduced en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Re-introduced Is a Non-availability indicator true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Perindopril erbumine 4mg / Amlodipine 5mg tablets (Alliance Healthcare (Distribution) Ltd) 30 tablet 3 x 10 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Tenormin 5mg/10ml solution for injection ampoules (Atnahs Pharma UK Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Apollo Pro-Shield Safety Pen hypodermic insulin needles for pre-filled / reusable pen injectors screw on 5mm/30gauge (Apollo Medical Technologies Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Perindopril erbumine 4mg / Amlodipine 10mg tablets (A A H Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Perindopril erbumine 4mg / Amlodipine 10mg tablets (Krka UK Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Atenolol 5mg/10ml solution for injection ampoules 10 ampoule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Perindopril erbumine 8mg / Amlodipine 5mg tablets (A A H Pharmaceuticals Ltd) 30 tablet 3 x 10 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Perindopril erbumine 8mg / Amlodipine 5mg tablets (Krka UK Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Perindopril erbumine 8mg / Amlodipine 10mg tablets (A A H Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Perindopril erbumine 4mg / Amlodipine 10mg tablets (Alliance Healthcare (Distribution) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Apollo Pro-Shield Safety Pen hypodermic insulin needles for pre-filled / reusable pen injectors screw on 5mm/30gauge (Apollo Medical Technologies Ltd) 100 needle VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Perindopril erbumine 8mg / Amlodipine 5mg tablets (Alliance Healthcare (Distribution) Ltd) 30 tablet 3 x 10 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Perindopril erbumine 4mg / Amlodipine 10mg tablets 30 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Perindopril erbumine 4mg / Amlodipine 5mg tablets 30 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Perindopril erbumine 8mg / Amlodipine 10mg tablets (Alliance Healthcare (Distribution) Ltd) 30 tablet 3 x 10 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Perindopril erbumine 4mg / Amlodipine 5mg tablets (Alliance Healthcare (Distribution) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Perindopril erbumine 8mg / Amlodipine 10mg tablets (Krka UK Ltd) 30 tablet 3 x 10 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Perindopril erbumine 8mg / Amlodipine 5mg tablets 30 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Amiloride 5mg / Bumetanide 1mg tablets (Medihealth (Northern) Ltd) 28 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Amiloride 5mg / Bumetanide 1mg tablets (Medihealth (Northern) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ramipril 5mg capsules (Milpharm Ltd) 28 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ramipril 5mg capsules (Milpharm Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Atropine 1% eye drops (Medihealth (Northern) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ramipril 2.5mg capsules (Milpharm Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Bimatoprost 300micrograms/ml eye drops (Medihealth (Northern) Ltd) 3 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Losartan 25mg tablets (Torrent Pharma (UK) Ltd) 28 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Atropine 1% eye drops (Medihealth (Northern) Ltd) 10 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Losartan 25mg tablets (Torrent Pharma (UK) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ramipril 2.5mg capsules (Milpharm Ltd) 28 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Bimatoprost 300micrograms/ml eye drops (Medihealth (Northern) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely metoclopramide hydrochloride 5 milligram and paracetamol 500 milligram/1 sachet effervescent powder for conventional release oral suspension VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Calcipotriol 0.005% / Betamethasone dipropionate 0.05% ointment (Medihealth (Northern) Ltd) 30 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Paramax sachets (Sanofi-Synthelabo Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Calcipotriol 50micrograms/g ointment (Medihealth (Northern) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Cefalexin 250mg/5ml oral suspension (Medihealth (Northern) Ltd) 100 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Paracetamol 500mg / Metoclopramide 5mg effervescent powder sachets sugar free 42 sachet VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Paramax sachets (Sanofi-Synthelabo Ltd) 42 sachet VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Calcipotriol 50micrograms/g ointment (Medihealth (Northern) Ltd) 30 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Cefalexin 250mg/5ml oral suspension (Medihealth (Northern) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Calcipotriol 0.005% / Betamethasone dipropionate 0.05% ointment (Medihealth (Northern) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Calcipotriol 50micrograms/g ointment (Medihealth (Northern) Ltd) 60 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Calcipotriol 50micrograms/g ointment (Medihealth (Northern) Ltd) 120 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Generic Dianeal PD4 Glucose 1.36% solution for peritoneal dialysis 5litre bags VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dicycloverine 10mg tablets (Medihealth (Northern) Ltd) 100 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Generic Volulyte 6% infusion 500ml bags 1 bag VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Co-trimoxazole 40mg/200mg/5ml oral suspension sugar free (Medihealth (Northern) Ltd) 100 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Co-danthrusate 50mg/60mg/5ml oral suspension sugar free (Medihealth (Northern) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Volulyte 6% infusion 500ml Freeflex bags (Fresenius Kabi Ltd) 1 bag VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Dianeal PD4 Glucose 1.36% solution for peritoneal dialysis 5litre System 2 single bags with luer connector (Baxter Healthcare Ltd) 1 bag VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Generic Dianeal PD4 Glucose 1.36% solution for peritoneal dialysis 5litre bags 2 bag VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dicycloverine 20mg tablets (Medihealth (Northern) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dicycloverine 10mg tablets (Medihealth (Northern) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dianeal PD4 Glucose 1.36% solution for peritoneal dialysis 5litre System 2 single bags with luer connector (Baxter Healthcare Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dicycloverine 10mg/5ml oral solution (Medihealth (Northern) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dianeal PD4 Glucose 1.36% solution for peritoneal dialysis 5litre System 2 single bags with luer connector (Baxter Healthcare Ltd) 2 bag VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Co-trimoxazole 40mg/200mg/5ml oral suspension sugar free (Medihealth (Northern) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Co-danthrusate 50mg/60mg/5ml oral suspension sugar free (Medihealth (Northern) Ltd) 200 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dicycloverine 20mg tablets (Medihealth (Northern) Ltd) 84 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Generic Dianeal PD4 Glucose 1.36% solution for peritoneal dialysis 5litre bags 1 bag VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dicycloverine 10mg/5ml oral solution (Medihealth (Northern) Ltd) 120 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Heparin sodium 500units/500ml solution for infusion bags VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Medroxyprogesterone 150mg/1ml suspension for injection vials VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Esomeprazole 20mg gastro-resistant capsules (Medihealth (Northern) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Medroxyprogesterone 150mg/1ml suspension for injection vials 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Levomepromazine 6mg tablets (Morningside Healthcare Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Doxepin 50mg capsules (Medihealth (Northern) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Depo-Provera 150mg/1ml suspension for injection vials (Pfizer Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Depo-Provera 150mg/1ml suspension for injection vials (PI) (Waymade Ltd) 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Heparin sodium 500units/500ml infusion Viaflex bags (Baxter Healthcare Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Depo-Provera 150mg/1ml suspension for injection vials (Pfizer Ltd) 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Depo-Provera 150mg/1ml suspension for injection vials (Sigma Pharmaceuticals Plc) 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Heparin sodium 500units/500ml infusion bags 20 bag VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Doxepin 50mg capsules (Medihealth (Northern) Ltd) 28 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Doxepin 25mg capsules (Medihealth (Northern) Ltd) 28 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Heparin sodium 500units/500ml solution for infusion bags 1 bag VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Esomeprazole 20mg gastro-resistant capsules (Medihealth (Northern) Ltd) 28 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Heparin sodium 500units/500ml infusion Viaflex bags (Baxter Healthcare Ltd) 20 bag VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Heparin sodium 500units/500ml infusion Viaflex bags (Baxter Healthcare Ltd) 1 bag VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Esomeprazole 40mg gastro-resistant capsules (Medihealth (Northern) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Levomepromazine 6mg tablets (Morningside Healthcare Ltd) 28 tablet 2 x 14 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Depo-Provera 150mg/1ml suspension for injection vials (Sigma Pharmaceuticals Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Depo-Provera 150mg/1ml suspension for injection vials (PI) (Waymade Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Esomeprazole 40mg gastro-resistant capsules (Medihealth (Northern) Ltd) 28 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Doxepin 25mg capsules (Medihealth (Northern) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Mezolar Matrix 100micrograms/hour transdermal patches (Pilsco Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Mezolar Matrix 25micrograms/hour transdermal patches (Pilsco Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Mezolar Matrix 50micrograms/hour transdermal patches (Pilsco Ltd) 5 patch VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Mezolar Matrix 25micrograms/hour transdermal patches (Pilsco Ltd) 5 patch VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Mezolar Matrix 100micrograms/hour transdermal patches (Pilsco Ltd) 5 patch VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Mezolar Matrix 75micrograms/hour transdermal patches (Pilsco Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Mezolar Matrix 75micrograms/hour transdermal patches (Pilsco Ltd) 5 patch VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Mezolar Matrix 50micrograms/hour transdermal patches (Pilsco Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dalonev ointment (Mibe Pharma UK Ltd) 120 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dalonev ointment (Mibe Pharma UK Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dalonev ointment (Mibe Pharma UK Ltd) 60 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dalonev ointment (Mibe Pharma UK Ltd) 30 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Meningococcal C conjugate vaccine suspension for injection 0.5ml pre-filled syringes VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely lactic acid 50 milligram/1 gram and urea 100 milligram/1 gram conventional release cutaneous cream VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Alverine 60mg / Simeticone 300mg capsules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Udrate cream (Ennogen Healthcare Ltd) 100 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Calmurid cream (Lexon (UK) Ltd) 100 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier

Start Previous Page 18 of 86 Next End


This concept is not in any reference sets

Back to Start